Barrett & Company’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Barrett & Company’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$224K	Hold	905	–	–	0.06%	156
2026 Q1	$182K	Hold	905	–	–	0.06%	161
2025 Q4	$187K	Hold	905	–	–	0.06%	156
2025 Q3	$162K	Hold	905	–	–	0.06%	170
2025 Q2	$146K	Sell	905 -55	-6%	-$8.76K	0.05%	173
2025 Q1	$163K	Hold	960	–	–	0.07%	150
2024 Q4	$160K	Hold	960	–	–	0.07%	153
2024 Q3	$165K	Hold	960	–	–	0.07%	150
2024 Q2	$148K	Hold	960	–	–	0.07%	158
2024 Q1	$148K	Hold	960	–	–	0.07%	154
2023 Q4	$152K	Hold	960	–	–	0.08%	143
2023 Q3	$140K	Hold	960	–	–	0.08%	142
2023 Q2	$147K	Hold	960	–	–	0.09%	144
2023 Q1	$149K	Hold	960	–	–	0.09%	143
2022 Q4	$148K	Hold	960	–	–	0.1%	134
2022 Q3	$148K	Buy	+960	New	+$135K	0.1%	134

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Barrett & Company's FBT Position: Q2 2026 in Review

Barrett & Company held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 905 shares worth $224K. The position accounts for 0.06% of the portfolio, ranked #156.

Barrett & Company first reported a position in FBT in Q3 2022 and has held it in 16 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Barrett & Company held 905 shares of First Trust NYSE Arca Biotechnology Index Fund worth $224K as of Q2 2026.
Barrett & Company left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.06% of Barrett & Company's portfolio in Q2 2026, its #156 holding.
Barrett & Company first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2022 and has held it in 16 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.